These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5950564)

  • 1. Plasminogen activator in mouse uterine fluid: its suppression by estradiol and progesterone.
    Harpel P; Bang NU; Homburger F; Treger A
    Proc Soc Exp Biol Med; 1966; 122(4):1192-5. PubMed ID: 5950564
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of specific hormones on fibrinolysis in pregnancy.
    Houlihan CM; Knuppel RA; Vintzileos AM; Guo JZ; Hahn DW
    Am J Obstet Gynecol; 1996 Jul; 175(1):168-72. PubMed ID: 8694045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro zona-lytic activity in uterine fluid from ovariectomized mice treated with oestradiol-17 beta and progesterone.
    Hoversland RC; Weitlauf HM
    J Reprod Fertil; 1982 Jan; 64(1):223-6. PubMed ID: 7054495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity of rat uterine fluid.
    Rasmussen J; Albrechtsen OK; Astrup T
    Experientia; 1970 Aug; 26(8):841-2. PubMed ID: 5452005
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen, progesterone, and the blood-uterine lumen permeability barrier in rats.
    McRae AC; Kennedy TG
    Biol Reprod; 1981 Sep; 25(2):314-20. PubMed ID: 7306627
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal cohtrol of uterine lumen fluid retention in the rat.
    Armstrong DT
    Am J Physiol; 1968 Apr; 214(4):764-71. PubMed ID: 5689310
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of estrogen and progesterone on the volume and electrolyte content of the uterine luminal fluid of the rat.
    Tantayaporn P; Mallikarjuneswara VR; de Carlo J; Clemetson CA
    Endocrinology; 1974 Oct; 95(4):1034-45. PubMed ID: 4416234
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of progesterone on norepinephrine release from mouse adrenergic terminals in vitro.
    Padilla L; Asencio H; Fernandez W; Cruz MA; Neumann V; Reinicke K; Rudolph MI
    Gen Pharmacol; 1991; 22(4):647-50. PubMed ID: 1936897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of a low-molecular-weight protein in oviductal and uterine fluids by ovarian hormones.
    Goswami A; Feigelson M
    Endocrinology; 1974 Sep; 95(3):669-75. PubMed ID: 4851387
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties.
    Peltz SW; Katzenellenbogen BS; Kneifel MA; Mangel WF
    Endocrinology; 1983 Mar; 112(3):890-7. PubMed ID: 6681601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of steroid hormones on fibrinolytic system in cultured human endometrial cells.
    Miyauchi A; Osuga Y; Taketani Y
    Endocr J; 1995 Feb; 42(1):57-62. PubMed ID: 7599699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.
    Rider V; Isuzugawa K; Twarog M; Jones S; Cameron B; Imakawa K; Fang J
    J Endocrinol; 2006 Dec; 191(3):537-48. PubMed ID: 17170212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin F in moneky uterine fluid during the menstrual cycle and following steroid treatment.
    Demers LM; Yoshinaga K; Greep RO
    Prostaglandins; 1974 Mar; 5(6):513-9. PubMed ID: 4207074
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the pituitary in modifications of the uterine secretion of spayed, oestradiol-primed rats.
    Meglioli G; Desaulles PA
    Horm Res; 1973; 4(6):367-75. PubMed ID: 4775454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of estradiol dipropionate and progesterone on the histology of the vagina and uterus of the mouse.
    Tripathi G
    J Exp Zool; 1984 Oct; 232(1):151-5. PubMed ID: 6502091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of relaxin on uterine motility and tonus in vitro and in vivo following treatment with oestradiol and progesterone.
    WIQVIST N
    Acta Endocrinol (Copenh); 1959 Jul; 31(3):391-9. PubMed ID: 13669936
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of endometrial plasminogen activator to fibrin proteolysis in the uterine cavity of rhesus monkeys.
    Shaw ST; Jimenez JM; Moyer DL; Cihak RW
    Am J Obstet Gynecol; 1973 Apr; 115(7):983-5. PubMed ID: 4633005
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.